• Price (MXN)813.95
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-2.38%
  • Beta0.9363
Data delayed at least 20 minutes, as of Oct 02 2019 11:30 BST.
More ▼

Key statistics

On Wednesday, Novozymes A/S (NZYMN:MEX) closed at 813.95, 0.00% above its 52-week low of 813.95, set on Oct 02, 2019.
52-week range
813.95Oct 02 2019830.61Sep 30 2019
Markit short selling activity
Previous close813.95
Average volume--
Shares outstanding231.26m
Free float157.05m
P/E (TTM)37.34
Market cap91.92bn DKK
EPS (TTM)10.65
Annual div (ADY)--
Annual div yield (ADY)--
Div ex-dateFeb 28 2019
Div pay-dateMar 04 2019
Data delayed at least 20 minutes, as of Oct 02 2019 11:30 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.